Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 2
This trial is for people with non small cell lung cancer that has spread to the brain or the membranes covering the brain and spinal cord (the leptomeninges). The tumour must also have a change to a protein called anaplastic lymphoma kinase (ALK).
Recruitment start: 29 October 2015
Recruitment end: 20 April 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Joyce Thompson
Novartis
Last reviewed: 19 April 2017
CRUK internal database number: 13654